SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-046726
Filing Date
2024-11-14
Accepted
2024-11-14 07:51:06
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ef20034540_10q.htm   iXBRL 10-Q 1241359
2 EXHIBIT 10.1 ef20034540_ex10-1.htm EX-10.1 102527
3 EXHIBIT 31.1 ef20034540_ex31-1.htm EX-31.1 11710
4 EXHIBIT 31.2 ef20034540_ex31-2.htm EX-31.2 12015
5 EXHIBIT 32.1 ef20034540_ex32-1.htm EX-32.1 5769
6 EXHIBIT 32.2 ef20034540_ex32-2.htm EX-32.2 5619
  Complete submission text file 0001140361-24-046726.txt   6351330

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20240930.xsd EX-101.SCH 46083
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20240930_cal.xml EX-101.CAL 34739
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20240930_def.xml EX-101.DEF 249666
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20240930_lab.xml EX-101.LAB 608656
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20240930_pre.xml EX-101.PRE 393549
66 EXTRACTED XBRL INSTANCE DOCUMENT ef20034540_10q_htm.xml XML 881790
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 241457248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)